Clinical Trial Update: Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension [Phase 2]

View source ↗

Summary

Phase II trial evaluating the safety and efficacy of LCZ696 (sacubitril/valsartan) on arterial stiffness in elderly patients with hypertension; the study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• LCZ696 (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2016-05-04